104 related articles for article (PubMed ID: 27174426)
1. Zebrafish model of photochemical thrombosis for translational research and thrombolytic screening in vivo.
Lee IJ; Yang YC; Hsu JW; Chang WT; Chuang YJ; Liau I
J Biophotonics; 2017 Apr; 10(4):494-502. PubMed ID: 27174426
[TBL] [Abstract][Full Text] [Related]
2. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model.
Matsuno H; Uematsu T; Nagashima S; Nakashima M
J Pharmacol Methods; 1991 Jul; 25(4):303-17. PubMed ID: 1909407
[TBL] [Abstract][Full Text] [Related]
3. Zebrafish thrombosis models according to the location of thrombus formation.
Hwang J; Koun S; Ha Y; Jung JM
Ann Transl Med; 2023 Jun; 11(9):309. PubMed ID: 37404988
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish (Danio rerio) Developed as an Alternative Animal Model for Focal Ischemic Stroke.
Yu X; Li YV
Acta Neurochir Suppl; 2016; 121():115-9. PubMed ID: 26463933
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic and thrombolytic efficacy of YM-254890, a G q/11 inhibitor, in a rat model of arterial thrombosis.
Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Nagai K; Inagaki O; Shikama H
Thromb Haemost; 2003 Sep; 90(3):406-13. PubMed ID: 12958608
[TBL] [Abstract][Full Text] [Related]
6. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
7. [A novel photochemical model of the middle cerebral artery for thrombosis research and evaluation of anti-thrombotic agents].
Umemura K
Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):175-85. PubMed ID: 9160347
[TBL] [Abstract][Full Text] [Related]
8. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosis.
Krupiński K; Giedrojć J; Breddin HK; Bielawiec M
Pol J Pharmacol; 1996; 48(3):345-50. PubMed ID: 9112675
[TBL] [Abstract][Full Text] [Related]
10. A canine coronary artery thrombosis model: application of photochemically induced thrombosis.
Umemura K; Ishiye M; Araki S; Nakashima M
Arch Int Pharmacodyn Ther; 1995; 330(1):13-24. PubMed ID: 8849307
[TBL] [Abstract][Full Text] [Related]
11. A Zebrafish Thrombosis Model for Assessing Antithrombotic Drugs.
Zhu XY; Liu HC; Guo SY; Xia B; Song RS; Lao QC; Xuan YX; Li CQ
Zebrafish; 2016 Aug; 13(4):335-44. PubMed ID: 27333081
[TBL] [Abstract][Full Text] [Related]
12. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
13. A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
Hirata Y; Umemura K; Takiguchi Y; Uematsu T; Nakashima M
Blood Coagul Fibrinolysis; 1993 Aug; 4(4):569-75. PubMed ID: 7692999
[TBL] [Abstract][Full Text] [Related]
14. Magnetically powered microwheel thrombolysis of occlusive thrombi in zebrafish.
Pontius MHH; Ku CJ; Osmond MJ; Disharoon D; Liu Y; Warnock M; Lawrence DA; Marr DWM; Neeves KB; Shavit JA
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2315083121. PubMed ID: 38408253
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic and clinical characteristics of thrombolytic agents.
Deitcher SR; Jaff MR
Rev Cardiovasc Med; 2002; 3 Suppl 2():S25-33. PubMed ID: 15112713
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic and Antiplatelet Effects of a Novel Plasminogen Activator from the Venom of Gloydius Brevicaudus Viper.
Zhang Z; Lin L; Zhang J; Zhang Q; Zhao N; Wu L; Chen J; Wu Z; Wu G; Lin J; Chen Y; Xu Y
J Atheroscler Thromb; 2015; 22(10):1080-90. PubMed ID: 26004931
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
Soni H; Sharma A; Bhatt S; Jain MR; Patel PR
Pharmacology; 2008; 82(4):304-9. PubMed ID: 18936552
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.
Tiukinhoy-Laing SD; Huang S; Klegerman M; Holland CK; McPherson DD
Thromb Res; 2007; 119(6):777-84. PubMed ID: 16887172
[TBL] [Abstract][Full Text] [Related]
19. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
20. Elongated Plant Virus-Based Nanoparticles for Enhanced Delivery of Thrombolytic Therapies.
Pitek AS; Wang Y; Gulati S; Gao H; Stewart PL; Simon DI; Steinmetz NF
Mol Pharm; 2017 Nov; 14(11):3815-3823. PubMed ID: 28881141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
